跳至主要内容
临床试验/NCT02424149
NCT02424149已完成不适用

Use of Phenazopyridine for Confirmation of Ureteral Patency During Intraoperative Cystoscopy

Hartford Hospital1 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
107
试验地点
1
主要终点
Time to Visualize Ureteral Urine Flow Intraoperatively Measured by Timing in the Operating Room

研究概览

简要总结

In this prospective, randomized trial subjects will be randomized to receive phenazopyridine or no medication prior to pelvic reconstructive procedures that use cystoscopy to confirm ureteral patency intraoperatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Females only
  • Planned surgical procedure where cystoscopy will be used to document ureteral urine flow
  • Age > or = 18 years, no upper age limit
  • Able and willing to consent

排除标准

  • Planned surgical procedure where cystoscopy will not be used
  • Planned surgical procedure where cystoscopy is used for a purpose other than documenting ureteral urine flow
  • age <18 years
  • pregnancy
  • unable/unwilling to participate
  • history of allergy or adverse reaction to phenazopyridine
  • hepatic dysfunction
  • known phenazopyridine hypersensitivity
  • history of urologic surgery
  • presence of ureteral stents prior to the planned surgical procedure
  • concomitant suprapubic catheter placement

研究组 & 干预措施

Phenazopyridine

Experimental

Preoperative phenazopyridine

干预措施: Phenazopyridine (Drug)

结局指标

主要结局

Time to Visualize Ureteral Urine Flow Intraoperatively Measured by Timing in the Operating Room

时间窗: Day of surgery

Timing was performed in the operating room. Time to visualize urine efflux was started at insertion of the cystoscope into the bladder, the time was considered complete when both ureteral orifices had displayed urine efflux.

次要结局

  • Physician Confidence Measured by a Survey(day of surgery (day 0))
  • Additional Interventions: Measured by Use of IV Fluids, IV Lasix, IV Methylene Blue, or Ureteral Stent Placement in OR(day of surgery (day 0))
  • Post-operative Urethral Discomfort Measured by Pain Scales(post operative day 1)
  • Trial of Void Results(Day of hospital discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katie Propst

Fellow

Hartford Hospital

研究点 (1)

Loading locations...

相似试验